ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development Post author: Post published:November 13, 2023 Post category:uncategorized ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. You Might Also Like Immune cells in overdrive: Study finds unbalanced response worsens lung infections February 8, 2024 Exploring how 25-hydroxycholesterol triggers ferroptosis in glial cells February 20, 2025 NIH-funded research enhances genetic testing for health equity February 20, 2024